Các bài viết có thể truy cập công khai - Elizabeth SmythTìm hiểu thêm
Không có ở bất kỳ nơi nào: 22
Tumor stage after neoadjuvant chemotherapy determines survival after surgery for adenocarcinoma of the esophagus and esophagogastric junction
AR Davies, JA Gossage, J Zylstra, F Mattsson, J Lagergren, N Maisey, ...
Journal of Clinical Oncology 32 (27), 2983-2990, 2014
Các cơ quan ủy nhiệm: Swedish Research Council, National Institute for Health Research, UK
Elevated platelet to lymphocyte ratio predicts poor prognosis after hepatectomy for liver-only colorectal metastases, and it is superior to neutrophil to lymphocyte ratio as an …
K Neofytou, EC Smyth, A Giakoustidis, AZ Khan, D Cunningham, ...
Medical oncology 31, 1-9, 2014
Các cơ quan ủy nhiệm: Cancer Research UK, National Institute for Health Research, UK
The preoperative lymphocyte-to-monocyte ratio is prognostic of clinical outcomes for patients with liver-only colorectal metastases in the neoadjuvant setting
K Neofytou, EC Smyth, A Giakoustidis, AZ Khan, R Williams, ...
Annals of surgical oncology 22, 4353-4362, 2015
Các cơ quan ủy nhiệm: National Institute for Health Research, UK
A pilot study assessing the incidence and clinical significance of circulating tumor cells in esophagogastric cancers
F Sclafani, E Smyth, D Cunningham, I Chau, A Turner, D Watkins
Clinical colorectal cancer 13 (2), 94-99, 2014
Các cơ quan ủy nhiệm: National Institute for Health Research, UK
Gastroesophageal cancer: Navigating the immune and genetic terrain to improve clinical outcomes
JO Jones, EC Smyth
Cancer treatment reviews 84, 101950, 2020
Các cơ quan ủy nhiệm: National Institute for Health Research, UK
Synchronous metastatic gastric cancer-molecular background and clinical implications with special attention to mismatch repair deficiency
K Polom, C Böger, E Smyth, D Marrelli, HM Behrens, L Marano, T Becker, ...
European Journal of Surgical Oncology 44 (5), 626-631, 2018
Các cơ quan ủy nhiệm: National Institute for Health Research, UK
Pathologic lymph node regression after neoadjuvant chemotherapy predicts recurrence and survival in esophageal adenocarcinoma: a multicenter study in the United Kingdom
JL Moore, M Green, A Santaolalla, H Deere, RPT Evans, M Elshafie, ...
Journal of Clinical Oncology 41 (28), 4522-4534, 2023
Các cơ quan ủy nhiệm: Cancer Research UK
The role of microsatellite instability in positive margin gastric cancer patients
K Polom, D Marrelli, EC Smyth, C Voglino, G Roviello, V Pascale, J Varas, ...
Surgical Innovation 25 (2), 99-104, 2018
Các cơ quan ủy nhiệm: National Institute for Health Research, UK, European Commission
Impaired expression of glutathione peroxidase-4 gene in peripheral blood mononuclear cells: a biomarker of increased breast cancer risk
G Bermano, E Smyth, M Goua, SD Heys, KWJ Wahle
Cancer Biomarkers 7 (1), 39-46, 2010
Các cơ quan ủy nhiệm: Chief Scientist Office, Scottish Executive
Emerging therapies for the management of Richter transformation
E Smyth, TA Eyre, CY Cheah
Journal of Clinical Oncology 41 (2), 395-409, 2023
Các cơ quan ủy nhiệm: National Institute for Health Research, UK
Immunotherapy in gastro-oesophageal cancer: current practice and the future of personalised therapy
ME Booth, EC Smyth
BioDrugs 36 (4), 473-485, 2022
Các cơ quan ủy nhiệm: National Institute for Health Research, UK
Pseudoprogression on treatment with immune-checkpoint inhibitors in patients with gastrointestinal malignancies: Case series and short literature review
V Michalarea, E Fontana, AI Garces, A Williams, EC Smyth, S Picchia, ...
Current Problems in Cancer 43 (5), 487-494, 2019
Các cơ quan ủy nhiệm: National Institute for Health Research, UK
Pathological tumor regression grade classifications in gastrointestinal cancers: role on patients’ prognosis
GN Fanelli, F Loupakis, E Smyth, M Scarpa, S Lonardi, S Pucciarelli, ...
International Journal of Surgical Pathology 27 (8), 816-835, 2019
Các cơ quan ủy nhiệm: Cancer Research UK
AREG and EREG as predictive biomarkers for RAS wild-type colorectal cancer treated with panitumumab: a fresh approach to an old puzzle
EC Smyth, K Khan, D Cunningham
JAMA oncology 2 (5), 578-579, 2016
Các cơ quan ủy nhiệm: National Institute for Health Research, UK
Pembrolizumab in first-line gastric cancer: win, lose, or draw?
EC Smyth, M Moehler
JAMA oncology 6 (10), 1539-1541, 2020
Các cơ quan ủy nhiệm: Federal Ministry of Education and Research, Germany
Ramucirumab: targeting angiogenesis in the treatment of gastric cancer
EC Smyth, N Tarazona, I Chau
Immunotherapy 6 (11), 1177-1186, 2014
Các cơ quan ủy nhiệm: National Institute for Health Research, UK
Optimal management of esophageal adenocarcinoma: should we be CROSS?
EC Smyth, TS Waddell, D Cunningham
Journal of Clinical Oncology 32 (27), 3080-3081, 2014
Các cơ quan ủy nhiệm: National Institute for Health Research, UK
Inconsistencies in the predictive value of PD-L1 in metastatic gastroesophageal cancer
R Sundar, EC Smyth
The Lancet Gastroenterology & Hepatology 9 (6), 495-497, 2024
Các cơ quan ủy nhiệm: National Institute for Health Research, UK
Combining chemotherapy, trastuzumab, and immune-checkpoint inhibitors in HER2-positive gastro-oesophageal cancer
EC Smyth, R Sundar
The Lancet 402 (10418), 2168-2170, 2023
Các cơ quan ủy nhiệm: US National Institutes of Health, National Institute for Health Research, UK
Highlights from the 2022 ASCO gastrointestinal cancer symposium: An overview by the EORTC gastrointestinal tract cancer group
F Sclafani, E Fontana, L Wyrwicz, AD Wagner, JW Valle, E Smyth, ...
Clinical colorectal cancer 21 (3), 188-197, 2022
Các cơ quan ủy nhiệm: European Commission, Federal Ministry of Education and Research, Germany
Chương trình máy tính sẽ tự động xác định thông tin xuất bản và thông tin về nhà tài trợ